Moderate Neuromuscular Blockade
Moderate Neuromuscular Blockade is a pharmaceutical drug with 6 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
80.0%
4 of 5 finished
20.0%
1 ended early
1
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Deep Versus Moderate Neuromuscular Blocking
Deep vs Moderate Neuromuscular Blockade With Rocuronium in Patients Undergoing Endolaryngeal Procedures
Deep vs Moderate Block: Impact on Operating Conditions & Patient Satisfaction
Deep Neuromuscular Block on Cytokines Release and Postoperative Delirium
Comparison of Deep Neuromuscular Block and Moderate Neuromuscular Block on Quality of Recovery in Patients Undergoing Robotic Gastrectomy
Clinical Trials (6)
Deep Versus Moderate Neuromuscular Blocking
Deep vs Moderate Neuromuscular Blockade With Rocuronium in Patients Undergoing Endolaryngeal Procedures
Deep vs Moderate Block: Impact on Operating Conditions & Patient Satisfaction
Deep Neuromuscular Block on Cytokines Release and Postoperative Delirium
Comparison of Deep Neuromuscular Block and Moderate Neuromuscular Block on Quality of Recovery in Patients Undergoing Robotic Gastrectomy
The Impacts of Surgical Visibility Through Deep Neuromuscular Blockade on Intraocular Pressure in Patients Undergoing Robot-Assisted Laparoscopic Radical Prostatectomy
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6